Quarterly Report 3 24/25

Precision Medicine for Autoimmune DiabetesAiming for Accelerated Market Approval Autoimmune or Type-1 Diabetes (T1D) is a progressive disease, diagnosed as at least two antibodies to the insulin producing beta cells are found. The disease advances to Stage-3 where the patient requires daily insulin administrations for survival. LADA (latent autoimmune diabetes in the adult), formerly often misdiagnosed as Type 2 Diabetes, is today reclassified as a form of Type 1 Diabetes. Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further